Stemtech (STEK) Total Current Liabilities (2012 - 2025)
Stemtech's (STEK) quarterly Total Current Liabilities came in at $10.6 million in Q4 2025, up 21.1% year-on-year from $8.7 million in Q4 2024, and up 2.77% quarter-over-quarter from $10.3 million in Q3 2025.
Stemtech (STEK) Total Current Liabilities (2012 - 2025) Analysis & Trends
Stemtech has disclosed Total Current Liabilities across 12 years of filings, most recently posting $10.6 million for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $10.6 million, up 21.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.6 million (up 21.1% YoY), and the FY2025 annual result was $10.6 million, up 21.1% from the prior year.
- Total Current Liabilities came in at $10.6 million for Q4 2025 at Stemtech, up from $10.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $33.3 million in Q2 2022 to a low of $5.7 million in Q2 2023.
- The 5-year median for Total Current Liabilities is $9.0 million (2022), against an average of $9.9 million.
- Across the five-year window, Total Current Liabilities slumped 82.87% in 2023 and surged 50.94% in 2024, its largest moves.
- Stemtech's Total Current Liabilities stood at $9.4 million in 2021, then slipped by 21.0% to $7.4 million in 2022, then declined by 12.86% to $6.5 million in 2023, then surged by 35.28% to $8.7 million in 2024, then increased by 21.1% to $10.6 million in 2025.
- The last three Total Current Liabilities figures came in at $10.6 million (Q4 2025), $10.3 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Stemtech | - | - | 354,677.00 | 10.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.59 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 9.44 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Jun 30, 2024 | 8.62 Mn |
| Mar 31, 2024 | 8.06 Mn |
| Dec 31, 2023 | 6.46 Mn |
| Sep 30, 2023 | 5.85 Mn |
| Jun 30, 2023 | 5.71 Mn |
| Mar 31, 2023 | 9.26 Mn |
| Dec 31, 2022 | 7.42 Mn |
| Sep 30, 2022 | 9.00 Mn |
| Jun 30, 2022 | 33.33 Mn |
| Mar 31, 2022 | 9.51 Mn |
| Dec 31, 2021 | 9.39 Mn |
| Sep 30, 2021 | 6.46 Mn |
| May 31, 2018 | 165,769.00 |
| Feb 28, 2018 | 147,081.00 |
| Nov 30, 2017 | 142,906.00 |